AKBA vs JD · rev $102.7M vs P/E 7.6, rev $187.20B
Akebia Ther (AKBA) versus JD.com Inc Adr (JD) — a side-by-side from cached financials, not a winner call.
Akebia Ther (AKBA) is a drug manufacturers - specialty & generic company listed on US.
JD.com Inc Adr (JD) is a internet retail company listed on US.
Latest reported AKBA revenue for 2026-06-30 was $102.7M. Net income was -$18.0M. Revenue was up 91.8% from 2026-03-31 to 2026-06-30. AKBA currently screens at market cap $260.1M.
Latest reported JD revenue for 2025-12-31 was $187.20B. Net income was $3.31B. Revenue was up 17.9% from 2024-12-31 to 2025-12-31. JD currently screens at market cap $45.56B and trailing P/E 7.6.
AKBA currently screens at market cap $260.1M. JD currently screens at market cap $45.56B and trailing P/E 7.6.
Not investment advice. Open the AKBA and JD stock pages for the full models.
Not investment advice.